Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Enabling Technologies and the Business of Science

Bio/Technology volume 13, pages 1172–1176 (1995)Cite this article

Abstract

The rapid pace of innovation, combined with tightening financial markets, is forcing new paradigms to emerge for the biotechnology business strategist

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Daniell, E. 1994. PCR in the Marketplace. Chapter 34, 421–426, in The Polymerase Chain Reaction, Mullis K.B., Ferr, F. & Gibbs, R.A. (Eds.), Birkhauser Boston.

    Chapter  Google Scholar 

  2. Lehrman, S. & Dickson, D., 1995. Promega, Roche clash over use of Taq in labs. Nature 375: 348.

    Article  CAS  Google Scholar 

  3. Fradd, R. and Engelberg, C. 1995. Biostocks near four-year low. Bio/Technology 13: 109–110.

    CAS  Google Scholar 

  4. Fradd, R.B. 1994. Third quarter sees stocks stop sliding. Bio/Technology 12: 1055–1056.

    Article  CAS  Google Scholar 

  5. Adler, P.S. 1989. Technology strategy: A guide to the literatures. Research in Technological Innovation, Management and Policy 4: 25–151.

    Google Scholar 

  6. Itami, H. 1987. Mobilizing Invisible Assets. Harvard University Press, London.

    Google Scholar 

  7. Clark, K. 1987. Investment in New Technology and Competitive Advantage. Ch. 3 in “The Competitive Challenge: Strategies for Industrial Innovation and Renewal”, Teece, D. (Ed.), Harper & Row, New York.

    Google Scholar 

  8. Dierickx, I. & Cool, K. 1989. Asset stock accumulation and sustainability of competitive advantage. Management Science 35: 1504–1513.

    Article  Google Scholar 

  9. Pisano, G.P. 1991. The Governance of Innovation: Vertical Integration and Collaborative Arrangements in the Biotechnology Industry. Research Policy 20: 237–249.

    Article  Google Scholar 

  10. Shan, W., Walker, G. & Kogut, B. 1994. Interfirm cooperation and startup innovation in the biotechnology industry. Strategic Management Journal 15: 387–394.

    Article  Google Scholar 

  11. Austin, D.H. 1993. An even-study approach to measuring innovative output: The case of biotechnology American Economic Review 83: 253–258.

    Google Scholar 

  12. Baum, R.M. 1994. Combinatorial approaches provide fresh leads for medicinal chemistry. Chemical & Engineering News Feb: 20–25.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. a research fellow at The Sol C. Snider Entrepreneurial Center, The Wharton School, The University of Pennsylvania, Vance Hall 4th Floor, 3733 Spruce Street, Philadelphia, PA, 19104

    Aris Persidis

Authors
  1. Aris Persidis
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Persidis, A. Enabling Technologies and the Business of Science. Nat Biotechnol 13, 1172–1176 (1995). https://doi.org/10.1038/nbt1195-1172

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt1195-1172

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing